(Q44612709)

English

Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors

scientific article published on October 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors (English)

1 reference

10.1016/S0301-472X(03)00200-5

https://api.crossref.org/works/10.1016/S0301-472X(03)00200-5

20 March 2024

lymphocyte transfusion

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550801

20 March 2024

Lymphocyte Depletion

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550801

20 March 2024

transplantation conditioning

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550801

20 March 2024

1 reference

10.1016/S0301-472X(03)00200-5

https://api.crossref.org/works/10.1016/S0301-472X(03)00200-5

20 March 2024

1 reference

10.1016/S0301-472X(03)00200-5

https://api.crossref.org/works/10.1016/S0301-472X(03)00200-5

20 March 2024

author name string

Susanne Osanto

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Roel Willemze

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Renée M. Y. Barge

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550801

20 March 2024

W. A F Erik Marijt

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550801

20 March 2024

C. W J Ingrid Starrenburg

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550801

20 March 2024

Willem E. Fibbe

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550801

20 March 2024

J. W R Hans Nortier

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550801

20 March 2024

J. H Frederik Falkenburg

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550801

20 March 2024

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

http://www.exphem.org/article/S0301472X03002005/pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550801

20 March 2024

https://api.elsevier.com/content/article/PII:S0301472X03002005?httpAccept=text/xml

1 reference

10.1016/S0301-472X(03)00200-5

https://api.crossref.org/works/10.1016/S0301-472X(03)00200-5

20 March 2024

https://api.elsevier.com/content/article/PII:S0301472X03002005?httpAccept=text/plain

1 reference

10.1016/S0301-472X(03)00200-5

https://api.crossref.org/works/10.1016/S0301-472X(03)00200-5

20 March 2024

Experimental Hematology

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

865-872

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of mixed hematopoietic chimerism and specific transplantation tolerance to allogeneic and xenogeneic grafts by selective elimination of donor-reactive host cells following nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Critical review on non-myeloablative stem cell transplantation (NST).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900200-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection

24

1 reference

10.1016/S0301-472X(03)00200-5

https://api.crossref.org/works/10.1016/S0301-472X(03)00200-5

20 March 2024

Identifiers

10.1016/S0301-472X(03)00200-5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44612709&oldid=2106637411"